Venous Thromboembolism in Patients with Heart Failure: In-hospital and Chronic Use of Anti-coagulants for Prevention

Author(s): Nasir Shariff, Abdul Aleem, Vadim Levin, Ravi V. Desai, Sudip Nanda, Matthew W. Martinez, Stacey J. Smith, Ronald Freudenberger

Journal Name: Recent Patents on Cardiovascular Drug Discovery
Continued as Recent Advances in Cardiovascular Drug Discovery

Volume 7 , Issue 1 , 2012


Heart failure (HF) is a common clinical syndrome characterized by high morbidity and frequent hospitalizations. HF is an independent and major risk factor for venous thromboembolism (VTE) and VTE occurring in patients with HF carries a worse prognosis. The present review will focus on short and long term role of anti-coagulants in prevention of venous thrombosis in HF patients. We will also be discussing the recently investigated and patented anti-coagulants which could have a role in this specific population.

Keywords: Congestive heart failure, prevention, venous thromboembolism, CHRONIC ANTICOAGULATION, ORAL ANTICOAGULATION, PARENTERAL ANTICOAGULATION, Rivaroxaban, Dabigatran, Apixaban, MAGELLAN

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [53 - 58]
Pages: 6
DOI: 10.2174/157489012799362395

Article Metrics

PDF: 20